Document Detail


Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus.
MedLine Citation:
PMID:  22264780     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
KCNJ11 polymorphisms have been linked to the risk of developing type 2 diabetes. Our aim was to define the contribution of KCNJ11 to new-onset diabetes after transplantation (NODAT) among patients treated with Tacrolimus (Tac). A total of 115 NODAT and 205 non-NODAT were genotyped for rs5219 (p.E23K). AA+AG genotypes were significantly associated with NODAT-risk (p=0.004; OR=2.10). The reported effect of this KCNJ11 polymorphism on insulin release by beta cells could explain this association.
Authors:
Beatriz Tavira; Eliecer Coto; Armando Torres; Carmen Díaz-Corte; Beatriz Díaz-Molina; Francisco Ortega; Manuel Arias; Juan M Díaz; Rafael Selgas; Carlos López-Larrea; Marta Ruiz-Ortega; Alberto Ortiz; Elena González; Josep M Campistol; Victoria Alvarez;
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-4
Journal Detail:
Title:  Molecular genetics and metabolism     Volume:  -     ISSN:  1096-7206     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9805456     Medline TA:  Mol Genet Metab     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Genética Molecular, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact of enzyme activity assay on indication in liver transplantation for ornithine transcarbamylas...
Next Document:  Spheres without Influence: Dissociating In Vitro Self-Renewal from Tumorigenic Potential in Glioma.